14β-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and Related Opioids. Further Examples of Pseudoirreversible μ Opioid Receptor Antagonists
摘要:
14 beta-4'-Chlorocinnamoylaminodihydronormorphinone (2a), and analogues, are selective pseudoirreversible antagonists of the mu opioid receptor (MOR). The preparation of analogues with ethynic bonds, replacing the ethenic bond of 2a, is described. The new ligands, in mouse antinociceptive assays, had pseudoirreversible MOR antagonist activity, which, in the case of 8b was of longer duration than that of 2a. The related codeinone (9b) had only antagonist activity in vivo, in contrast to 2a's codeinone equivalent 3a, which had potent antinociceptive activity.
New One-Step Synthesis of Functionalized 2-Imidazolines
作者:Alain Marsura、Cuong Luu-Duc、Gisèle Gellon
DOI:10.1055/s-1985-31267
日期:——
MARSURA, A.;DUC, GUONG, LUU, SYNTHESIS, BRD, 1982, N 7, 545
作者:MARSURA, A.、DUC, GUONG, LUU
DOI:——
日期:——
MARSURA, A.;LUU-DUC, CUONG;GELLON, G., SYNTHESIS, BRD, 1985, N 5, 537-541
作者:MARSURA, A.、LUU-DUC, CUONG、GELLON, G.
DOI:——
日期:——
14β-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and Related Opioids. Further Examples of Pseudoirreversible μ Opioid Receptor Antagonists
作者:Nick P.R. Nieland、David Rennison、Jillian H. Broadbear、Lauren Purington、James H. Woods、John R. Traynor、John W. Lewis、Stephen M. Husbands
DOI:10.1021/jm901074a
日期:2009.11.12
14 beta-4'-Chlorocinnamoylaminodihydronormorphinone (2a), and analogues, are selective pseudoirreversible antagonists of the mu opioid receptor (MOR). The preparation of analogues with ethynic bonds, replacing the ethenic bond of 2a, is described. The new ligands, in mouse antinociceptive assays, had pseudoirreversible MOR antagonist activity, which, in the case of 8b was of longer duration than that of 2a. The related codeinone (9b) had only antagonist activity in vivo, in contrast to 2a's codeinone equivalent 3a, which had potent antinociceptive activity.
Transmission of substituent effects through extended systems—III. p-Substituted ethyl trans cinnamates and phenylpropiolates